| 000 | 01813 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517032406.0 | ||
| 264 | 0 | _c20160728 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1549-4918 | ||
| 024 | 7 |
_a10.1002/stem.2050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGleeson, Birgitta M | |
| 245 | 0 | 0 |
_aBone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. _h[electronic resource] |
| 260 |
_bStem cells (Dayton, Ohio) _cSep 2015 |
||
| 300 |
_a2726-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aBone Marrow _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCoronary Vessels _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMesenchymal Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xmetabolism |
| 650 | 0 | 4 |
_aMicrovessels _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 |
_aThromboplastin _xmetabolism |
| 700 | 1 | _aMartin, Kenneth | |
| 700 | 1 | _aAli, Mohammed T | |
| 700 | 1 | _aKumar, Arun H S | |
| 700 | 1 | _aPillai, M Gopala-Krishnan | |
| 700 | 1 | _aKumar, Sujith P G | |
| 700 | 1 | _aO'Sullivan, John F | |
| 700 | 1 | _aWhelan, Derek | |
| 700 | 1 | _aStocca, Alessia | |
| 700 | 1 | _aKhider, Wisam | |
| 700 | 1 | _aBarry, Frank P | |
| 700 | 1 | _aO'Brien, Timothy | |
| 700 | 1 | _aCaplice, Noel M | |
| 773 | 0 |
_tStem cells (Dayton, Ohio) _gvol. 33 _gno. 9 _gp. 2726-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/stem.2050 _zAvailable from publisher's website |
| 999 |
_c24895797 _d24895797 |
||